41 – 50 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Remission maintenance in acute myeloid leukemia: impact of functional histamine H-2 receptors expressed by leukemic cells
- Contribution to journal › Article
-
Mark
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
- Contribution to journal › Article
- 2011
-
Mark
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
- Contribution to journal › Article
-
Mark
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
- Contribution to journal › Article
-
Mark
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
- Contribution to journal › Article
- 2010
-
Mark
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
- Contribution to journal › Article
-
Mark
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
- Contribution to journal › Article
- 2009
-
Mark
Autoimmunity and risk for Hodgkin's lymphoma by subtype
- Contribution to journal › Letter
-
Mark
Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma.
- Contribution to journal › Article
